Search

everythinglearnresearchcommunity

for

Search:↓

LTBP1 is a key regulator in diseases and a potential target for new treatments.

Baricitinib effectively promotes beard regrowth in most men with alopecia areata universalis.

EDA2R gene linked to hair loss.

Neurosteroids regulate synaptic inhibition in the spinal cord and may help manage spinal pain.

Different hair follicles in the skin are innervated by unique combinations of mechanosensory neurons, crucial for touch sensation.

The vitamin D receptor can affect gene activity even without its usual hormone in hair and skin.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

MILL molecules are unique immune proteins in mice that don't need TAP to appear on cell surfaces.

Mutations in the RBPJ gene cause Adams-Oliver Syndrome.

Dual TCR Treg cells are common in mouse tissues and vary by location.

Different people with severe hair loss respond to baricitinib treatment at different times, with some showing improvement early, some gradually, and others later.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Axolotls regenerate their spinal cord through a signal that recruits cells, influenced by cell sensitivity and signal spread.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Ca_v1.2 affects hair growth and could be a target for hair loss treatments.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

AVT is highly conserved and may have antimicrobial properties.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

A new compound from Royoporus badius activates immune cells and induces inflammatory responses.

Baricitinib is a promising treatment for alopecia areata.

Mutations in the ACTB gene cause Becker’s nevi and may lead to muscle issues in Becker’s nevus syndrome.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Ebastine may help regrow hair in alopecia areata patients.

CD2 might be a new treatment target for patchy alopecia areata.